Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
about
Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancerWhole genome expression profiling of blood cells in ovarian cancer patients -prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.miRNA Biomarkers in Breast Cancer Detection and ManagementNutrition and the prevention and treatment of cancer: association of cytochrome P450 CYP1B1 with the role of fruit and fruit extracts.CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro.Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors.A novel methodology for enhanced and consistent heterologous expression of unmodified human cytochrome P450 1B1 (CYP1B1).Polycyclic aromatic hydrocarbons and cytochrome P450 in HIV pathogenesis.CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation.Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.Development of an In Vitro Model to Screen CYP1B1-Targeted Anticancer Prodrugs.IKK-ε coordinates invasion and metastasis of ovarian cancer.Cytochrome P450 1B1: a novel anticancer therapeutic target.Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer managementPharmacogenetics and oncology treatment for breast cancer.CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic CaucasiansTargeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.A suite of activity-based probes for human cytochrome P450 enzymes.CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus.Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein.Unbalanced estrogen metabolism in ovarian cancerPharmacogenetics of chemotherapy efficacy in breast cancer.Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCCCytochrome P450 CYP1B1 activity in renal cell carcinoma.Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016).Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice.Molecular mechanisms of drug resistance in ovarian cancer.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer.Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity.
P2860
Q33889096-612C2C8F-4144-426E-A910-C105D6EC2C15Q33942459-6C60E58B-2A82-49AF-8920-4BE7A7E8C292Q34100848-17998664-458A-4FAA-9BD4-B8DCC0ADCA99Q34204238-FF186CCF-0E61-4074-91B5-985843C168C8Q34771896-25DDF475-8087-4723-B1A1-97909056AC7AQ34912607-D1C6FF7E-A87E-4EAD-9156-C97D4AC03449Q34936845-EC58B06E-6841-400B-9C9B-90C015BEBFCEQ35072792-2311A98E-B2B3-4FFB-821D-1858BBF7038BQ35349314-E910C765-F09B-4352-ADD8-7DBBC2A6E908Q35672088-EB6EE981-FBF4-41AB-BFBD-6FD59E88CB8DQ35959168-6B0AD7CC-BA60-43CB-9451-4CB4B54A27B4Q35966821-E26EEB19-2598-4F77-905B-242257718A16Q36264616-3787C7F8-EC79-4863-B6D7-6049CCDEA207Q36368532-E6F6280D-DA15-444A-AD1E-35BB0C7688FEQ36429453-D1EDC091-D5BB-41CD-8C56-BDA2104CBF17Q36441485-9EBECE9E-95F2-4C01-B72D-6C214EF20D82Q36719659-CC300A67-EFCB-4117-AA25-49BE7382F1F1Q36857575-3FF1A58D-41C1-4C70-B3F9-34883ACBBACFQ37030810-8E945364-A385-4101-8550-D7B7A628A236Q37259608-0ED74806-FED6-49E4-9725-09B5393F9C2FQ37331285-DD145838-1D1F-4A78-B69F-3D5B4970F283Q37340998-BCD51E10-F6C3-4B0A-B06B-2BF0D58EADB2Q37551896-BF8E8064-72DA-4704-BEFE-02A2E69798BDQ37629489-EC16D9AC-22A6-445A-A641-3A4276F77945Q38003703-B0474307-D27C-407C-B066-E17FB962355FQ38551666-99454F16-7C87-4AFD-ACB8-E52D7F6A23A8Q38622658-54FAFB31-46B3-41D0-A6F8-A0D6532BB95AQ38718489-57FF1FC6-935D-41C0-AAF6-7A49CD51C3C4Q38800931-5308ED63-645B-406D-9FE7-7C611E02494DQ39382164-CFC0C01F-3E75-4C87-A095-199E879FC4EFQ39702921-7267DAA7-A730-482B-9B67-D7BC239190A9Q41935784-5650EAFB-1FA4-42AF-8502-D93E5DADC444Q45174463-5BF9F038-FF1E-47D1-8AF5-8832E5E945AEQ48274587-11BB663C-CED4-4A9B-82D0-4F5028DC9A5EQ50179674-50FA49BB-0FBB-449B-A5AB-8727AD0002BCQ50526560-2588A7FE-D96E-4701-8A63-A24F9557B5CDQ50557593-E415C5AB-5E8D-42C4-B39E-084CF91BB526Q51764488-3B06271A-B88B-4113-8997-941B5A12FDEE
P2860
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@ast
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@en
type
label
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@ast
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@en
prefLabel
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@ast
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@en
P2093
P2860
P356
P1476
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
@en
P2093
G I Murray
H L McLeod
I D Miller
M E Cruickshank
N E Haites
W T Melvin
P2860
P2888
P304
P356
10.1054/BJOC.2001.1907
P407
P577
2001-07-01T00:00:00Z
P5875
P6179
1017956882